Breaking the ocular barrier through nano-lipid carriers to treat intraocular diseases
Journal of Drug Delivery Science and Technology, ISSN: 1773-2247, Vol: 87, Page: 104867
2023
- 3Citations
- 12Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Most Recent News
Breaking the ocular barrier through nano-lipid carriers to treat intraocular diseases
Abstract The human eye is a special organ. Its defense mechanisms protect it from invading microbes and harmful molecules. Treatment of different eye diseases often
Review Description
The human eye is a special organ. Its defense mechanisms protect it from invading microbes and harmful molecules. Treatment of different eye diseases often shows poor results due to the presence of these barriers. Nano lipid carriers have the capability to overcome these anatomical and physiological barriers effectively. It can also deliver the payload to the posterior eye. These non-toxic, biocompatible carriers significantly increase the ocular bioavailability of the drug. This review highlights the important ocular barriers and the way how nano lipid carriers overcome the tough ocular barriers.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1773224723007190; http://dx.doi.org/10.1016/j.jddst.2023.104867; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85168727487&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S1773224723007190; https://dx.doi.org/10.1016/j.jddst.2023.104867
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know